Get my own profile
Public access
View all4 articles
4 articles
available
not available
Based on funding mandates
Co-authors
- Dr. T. S. Keshava PrasadYenepoya (Deemed to be University), MangaloreVerified email at yenepoya.edu.in
- Arefian M.Plant Biotechnology Department, Ferdowsi University of Mashhad, Iran. (Arefian.m@gmail.com)Verified email at mail.um.ac.ir
- Cyrille BottéApicoLipid Group Head, CNRS Research Director, Institute for Advanced Biosciences CNRS UMR5309Verified email at univ-grenoble-alpes.fr
- Yoshiki Yamaryo-BottéResearch engineer Université Grenoble Alpes, ApicoLipid group, IAB, Grenoble, FranceVerified email at univ-grenoble-alpes.fr
- Keshava Datta, Ph.D.University of MelbourneVerified email at unimelb.edu.au
- Dr. Nicholas Katrisnicholas.katris@univ-grenoble-alpes.frVerified email at univ-grenoble-alpes.fr
- Sneha M. PintoSchool of Biosciences and Medicine, University of SurreyVerified email at surrey.ac.uk
- Santosh Kumar BeheraYenepoya (Deemed to be University)Verified email at yenepoya.edu.in
- Rex Devasahayam Arokia Balaya, MP...Mayo ClinicVerified email at mayo.edu
- manish kumarHarvard School of Public HealthVerified email at hsph.harvard.edu
Follow
Neelam Antil
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)
Verified email at fmp-berlin.de